Integration of Transcriptomic and CRISPR-Cas9 Technologies Reveal FOXA2 as a Tumor Suppressor Gene in Pancreatic Cancer

Christina Vorvis(University of California, Los Angeles)

eScholarship (California Digital Library)

January 1, 2016

Cited by 0

Related Papers

Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer

|American Journal of Physiology-Gastrointestinal and Liver Physiology|2016|54